Position in CLLS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,985
-$5,261 QoQ
Shares Held
3,150
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CLLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. CLLS ranks #291 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CLLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,985 | 3,150 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $15,246 | 3,150 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,977 | 3,150 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $26,153 | 17,150 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $28,210 | 22,750 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,262 | 24,590 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,630 | 12,090 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $23,917 | 12,790 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $34,291 | 12,940 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $44,025 | 14,294 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $24,559 | 15,544 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,327 | 15,919 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $31,804 | 16,479 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $35,655 | 16,979 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $39,453 | 17,229 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,476 | 11,829 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $58,697 | 12,929 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $158,111 | 19,472 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $423,947 | 33,620 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $447,545 | 28,930 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $615,837 | 30,472 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $726,073 | 26,832 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $521,644 | 28,197 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $549,449 | 30,868 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $350,077 | 38,052 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||